Baxter Healthcare Corporation has been the subject of 208 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for HISUN PHARM HANGZHOU.
Baxter Healthcare Corporation: 0 warning letters, 208 recalls, 0 approval records, 0 Form 483s.
HISUN PHARM HANGZHOU: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.
Side by side
Baxter Healthcare Corporation — Warning letters0
HISUN PHARM HANGZHOU — Warning letters0
Baxter Healthcare Corporation — Recalls208
HISUN PHARM HANGZHOU — Recalls0
Baxter Healthcare Corporation — Approval records0
HISUN PHARM HANGZHOU — Approval records1
Baxter Healthcare Corporation — Form 483s0
HISUN PHARM HANGZHOU — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Baxter Healthcare Corporation vs HISUN PHARM HANGZHOU: FDA Enforcement Comparison." Argus HQ, accessed July 29, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-hisun-pharm-hangzhou
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗